Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
36.34
+0.01 (0.03%)
Oct 22, 2026, 4:00 PM EDT - Market closed
Pacira BioSciences Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Hold Upgrades $23 → $37 | Hold | Upgrades | $23 → $37 | +0.44% | Oct 13, 2026 |
| Leerink Partners | Leerink Partners | Hold Reiterates $28 → $37 | Hold | Reiterates | $28 → $37 | +0.44% | Oct 9, 2026 |
| RBC Capital | RBC Capital | Hold Reiterates $25 → $37 | Hold | Reiterates | $25 → $37 | +0.44% | Oct 9, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades $38 → $37 | Hold | Downgrades | $38 → $37 | +0.44% | Oct 9, 2026 |
| Oppenheimer | Oppenheimer | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Oct 8, 2026 |
| Jefferies | Jefferies | Hold Downgrades $36 | Hold | Downgrades | $36 | -0.94% | Oct 8, 2026 |
| Needham | Needham | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Oct 8, 2026 |
| Truist Financial | Truist Financial | Hold Downgrades $31 → $37 | Hold | Downgrades | $31 → $37 | +0.44% | Oct 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.